Stories about Staphylococcus

Subscribe to Staphylococcus

17.09.2020 – 13:16

PAUL HARTMANN AG

HARTMANN launches Mission: Infection Prevention - how prevention is contagious

more
16.12.2019 – 17:07

Technische Universität München
From cancer medication to antibiotic: modified cancer drug effective against multi-resistant bacteria

TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center phone: +49 89 289 10510 - e-mail: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/nc/en/about-tum/news/press-releases/details/35822/ High resolution images: https://mediatum.ub.tum.de/1524870 NEWS RELEASE From cancer medication ...

more
29.03.2019 – 09:41

Micreos
Micreos Raises EUR30 Million for Endolysin Technology Set to Replace Antibiotics / Funding for clinical development program XZ.700 and Gladskin Eczema USA launch

THE HAGUE, Netherlands (ots) - Dutch biotechnology company Micreos announced it has secured EUR30 million in funding to accelerate the development of its endolysin technology, set to replace antibiotics. Proceeds are earmarked for the clinical development program of its endolysin XZ.700 and the USA launch of its ...

more
26.02.2019 – 09:00

Debiopharm International SA
Debiopharm International SA Initiates a Clinical Trial Phase II study evaluating afabicin in Bone and Joint Infections

Lausanne, Switzerland (ots) - Debiopharm International SA (Debiopharm - www.debiopharm.com/debiopharm-international/), part of Debiopharm Group(TM), a Swiss-based global biopharmaceutical company, today announced the start of a clinical phase II study to evaluate its antibiotic afabicin (Debio 1450) ( ...

more
21.02.2019 – 09:48

Technische Universität München
Salt could be a key factor in allergic immune reactions like atopic dermatitis

TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center phone: +49 89 289 22731 - email: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/nc/en/about-tum/news/press-releases/detail/article/35257/ Pictures: https://mediatum.ub.tum.de/1475815 NEWS RELEASE Salt could be a key factor in allergic immune reactions Atopic dermatitis: elevated ...

more
20.05.2011 – 16:37

Astellas Pharma Europe Limited
Astellas Receives Positive Opinion From CHMP for European Approval of VIBATIV(TM) for Nosocomial Pneumonia Caused by MRSA

Staines, England (ots/PRNewswire) - Astellas Pharma Europe Ltd., announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a positive opinion, recommending the granting of marketing authorisation for VIBATIV (telavancin hydrochloride) for the ...

more

1